Question · asked by 1 review

Commercial mouthcare system (Biotene Oral Balance / Xerostom) vs Usual care or CMC-based control: Quality of life (xerostomia-related)

Population
Adults seeking treatment for the symptom of dry mouth (xerostomia) due to any cause (e.g. medication, Sjogren's syndrome, radiotherapy, haemodialysis)
Intervention
Commercial mouthcare system (Biotene Oral Balance / Xerostom)
Comparison
Usual care or CMC-based control
Outcome
Quality of life (xerostomia-related)

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Commercial mouthcare system (Biotene Oral Balance / Xerostom) vs Usual care or CMC-based control
Quality of life (xerostomia-related) · Adults seeking treatment for the symptom of dry mouth (xerostomia) due to any cause (e.g. medication, Sjogren's…
Interventions for the management of dry mouth: topical therapies (2011) · Cochrane All outcomes
Ship 2007 reported xerostomia-related quality of life; no usable comparative data.1 studyGRADE not reported

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Interventions for the management of dry mouth: topical therapies
2011 · Cochrane All outcomes
2011-10Not listedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.